Position in UTHR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,846,127
-$281,964 QoQ
Shares Held
8,944
+3.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#254
of 870 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $48,172,745 across 31 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
419,136 | $6,655,879 | |
| 2 | ZTS |
Zoetis Inc.
|
81,282 | $5,840,924 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
8,944 | $4,846,127 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
26,150 | $4,407,321 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
120,099 | $4,163,832 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
122,056 | $3,003,798 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
85,581 | $2,899,484 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
152,601 | $2,446,194 |
All Filings in UTHR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,846,127 | 8,944 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,128,091 | 8,648 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,049,047 | 8,310 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,920,636 | 6,967 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,277,823 | 7,927 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,473,558 | 8,024 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,075,000 | 8,715 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,957,104 | 8,252 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,964,497 | 6,167 | Shares | Sole | 2024-08-22 | |
| 2023-12-31 | $584,687 | 2,659 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $556,091 | 2,462 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $497,129 | 2,252 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $438,289 | 1,957 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $542,553 | 1,951 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $242,671 | 1,159 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $225,271 | 956 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||